The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
07 05 2019
Historique:
pubmed: 30 4 2019
medline: 14 1 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

The chylomicronemia syndrome occurs when triglyceride levels are severely elevated (usually >16.95 mmol/L [1500 mg/dL]) and is characterized by such clinical features as abdominal pain, acute pancreatitis, eruptive xanthomas, and lipemia retinalis. It may result from 1 of 3 conditions: the presence of secondary forms of hypertriglyceridemia concurrent with genetic causes of hypertriglyceridemia, termed multifactorial chylomicronemia syndrome (MFCS); a deficiency in the enzyme lipoprotein lipase and some associated proteins, termed familial chylomicronemia syndrome (FCS); or familial partial lipodystrophy. Most chylomicronemia syndrome cases are the result of MFCS; FCS is very rare. In all these conditions, triglyceride-rich lipoproteins accumulate because of impaired plasma clearance. This review describes the 3 major causes of the chylomicronemia syndrome; their consequences; and the approaches to treatment, which differ considerably by group.

Identifiants

pubmed: 31035285
pii: 2732076
doi: 10.7326/M19-0203
doi:

Substances chimiques

Angiopoietins 0
Apolipoproteins 0
Chylomicrons 0
Fatty Acids, Omega-3 0
Fibric Acids 0
GPIHBP1 protein, human 0
Hypolipidemic Agents 0
Oligonucleotides 0
Receptors, Lipoprotein 0
Lipoprotein Lipase EC 3.1.1.34

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

626-634

Auteurs

Alan Chait (A)

University of Washington, Seattle, Washington (A.C.).

Robert H Eckel (RH)

University of Colorado Anschutz Medical Campus, Aurora, Colorado (R.H.E.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH